Drug intelligence / Profile preview

Modified Umbilical Cord derived MSCs

Development stage
Preclinical
Lead developer
StemiGen
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intrathecal, Pancreas Injection, Intraperitoneal, Dorsal Pancreatic Artery Injection, Central Venous Catheter Infusion
01

Overview

Modified Umbilical Cord derived MSCs is an engineered cell therapy being developed by StemiGen for the treatment of knee osteoarthritis. These mesenchymal stem cells (MSCs) are derived from the umbilical cord and have been modified or engineered to enhance their therapeutic potential, specifically targeting improved regenerative or immunomodulatory activity within the joint environment. By leveraging the anti-inflammatory and tissue-repair capabilities of MSCs, the therapy aims to mitigate the progression of osteoarthritis and promote joint health. The program is currently in the discovery/preclinical stage of development.

Other names
Modified umbilical cord-derived mesenchymal stem cellsEngineered umbilical cord-derived mesenchymal stem cellsModified UC-MSCs

Beyond the preview

Go deeper on Modified Umbilical Cord derived MSCs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modified Umbilical Cord derived MSCs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call